FDA Announcement On Foreign Flu Vaccine Supply Expected By Dec. 3
This article was originally published in The Pink Sheet Daily
Executive Summary
The agency has completed inspections of foreign facilities and is considering whether the vaccines manufactured there are appropriate for use as investigational new drugs, HHS says.
You may also be interested in...
Medicare Rx Regional Map Proposal Expected Week Of Dec. 6
The proposed regional map for competition among private plans participating in the Medicare prescription drug benefit is expected to be unveiled the week of Dec. 6
Medicare Rx Regional Map Proposal Expected Week Of Dec. 6
The proposed regional map for competition among private plans participating in the Medicare prescription drug benefit is expected to be unveiled the week of Dec. 6
Excess Foreign Flu Vaccine Supply Could Add 6 Mil. Doses To U.S.
FDA hopes that some or all of the excess foreign flu vaccine will be available for U.S. use by year-end, FDA Acting Commissioner Crawford tells Senate subcommittee. FDA should finish reviewing 750,000 doses of foreign vaccine purchased through distribution channels by cities and states in two to three weeks, Crawford says.